Skip to search form Skip to main content. Predictors and timing of recovery in patients with immediate facial nerve dysfunction after parotidectomy. METHODS In this 6-year retrospective cohort study, 54 such patients were analyzed to determine the associated prognostic factors and timing of recovery.
Sialosis or sialadenosis Case example of surgical treatment. Case Example Parotid Lipoma-like Liposarcoma. The sample dictation below is not intended to be used as a template.
METHODS: Over a year period, patients with normal facial nerve function underwent a superficial or total conservative parotidectomy with nerve dissection performed by one surgeon for primary benign or malignant tumors. Facial nerve function was assessed on the first postoperative day and at 1 month and 6 months after the parotidectomy. Extent of surgery, histopathological findings, tumor size, close contact of tumor with facial nerve, and sex and age of the patient were reviewed.
Parotidectomy is the removal of part or all of the parotid gland on one side of the face. Understanding the anatomy of the facial nerve as it relates to the parotid gland is key to understanding the surgery. In some cases, additional procedures might be done at the same time as the parotidectomy. For example, a neck dissection might be indicated in certain types of parotid cancer, a facial nerve graft might be done if part or all of the facial nerve has to be sacrificed or a temporal bone resection might be required if the parotid cancer is growing into the side of the head where the ear is located.
Background Parotidectomy was first introduced into the world literature by Berard in who removed a parotid tumor of 8 years' duration. Since then the procedure has been modified and applied to a variety of benign and malignant conditions affecting the gland; superficial parotidectomy, subtotal parotidectomy, and total parotidectomy are now the options available to the head and neck surgeon. The primary goal of parotid surgery is the complete removal of tumors while preserving facial nerve function.
Parotid tumors are the most common type of salivary gland tumors, accounting for 80 to 85 percent of all salivary gland tumors. While most parotid tumors are noncancerous benignthe parotid glands are where nearly 25 percent of cancerous malignant salivary gland tumors develop. The parotid glands, located just in front of the ears on each side of the face, are the largest of the three sets of major salivary glands.
Background: The majority of parotid masses are benign pleomorphic adenomas that rarely recur, leaving a large group of patients healthy after their parotid surgery. The optimal treatment for benign parotid tumors, of which pleomorphic adenomas is the most common is superficial parotidectomy with dissection and preservation of the facial nerve. Aims and Objectives: The aim of this study was to evaluate the postoperative complications and tumor recurrence following superficial parotidectomy for benign parotid tumors.
These tumors occur predominantly in major salivary glands. The parotid gland is affected most often, ranging from Several surgical approaches have been described to treat this tumor.
Babak Larian, Dr. Babak Azizzadeh and Dr. William Slattery at the CENTER have earned international acclaim for their successful outcomes in facial nerve preservation during parotid surgery.